An official website of the United States government

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2022
Affiliation
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Pediatric Gastroenterology and Hepatology, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.; Division of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Pediatrics, Feinberg Medical School of Northwestern University, Chicago, Illinois, USA.; Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, St. Louis University, St. Louis, Missouri, USA.; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.; Department of Pediatrics, Feinberg Medical School of Northwestern University, Chicago, Illinois, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Indiana University School of Medicine/Riley Hospital for Children, Indianapolis, Indiana, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Authors
Vos Miriam B, Van Natta Mark L, Blondet Niviann M, Dasarathy Srinivasan, Fishbein Mark, Hertel Paula, Jain Ajay K, Karpen Saul J, Lavine Joel E, Mohammad Saeed, Miriel Laura A, Molleston Jean P, Mouzaki Marialena, Sanyal Arun, Sharkey Emily P, Schwimmer Jeffrey B, Tonascia James, Wilson Laura A, Xanthakos Stavra A

Abstract

To date, no pharmacotherapy exists for pediatric NAFLD. Losartan, an angiotensin II receptor blocker, has been proposed as a treatment due to its antifibrotic effects.